Naborforce vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Richmond VA YC W20 on-demand senior companion platform with 1,000%+ pandemic revenue growth; $13.5M total ($9M Translink Series A 2022) connecting older adults with vetted Nabors for companionship, errands, and transportation competing with Papa.
About
Naborforce is a Richmond, Virginia-based on-demand senior companionship and assistance platform — backed by Y Combinator (W20) with approximately $13.5 million in total funding including a $9 million Series A in August 2022 led by Translink Capital with Claritas Capital, The Artemis Fund, and TechStars — providing older adults with on-demand access to a vetted network of 'Nabors' (friendly helpers who are not healthcare providers) for social engagement, companionship, errands, transportation, and light assistance around the home. Founded in 2016, Naborforce grew revenue over 1,000% and expanded its client base over 800% during the COVID-19 pandemic, demonstrating the pent-up demand for senior social connection and practical assistance services.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.